Leveraging Generative AI On AWS To Transform Life Sciences
IBM News, Wednesday, July 19,2023
The exponential leap in generative AI is already transforming many industries: optimizing workflows, helping human teams focus on value added tasks and accelerating time to market.
Life sciences industry is beginning to take notice and aims to leapfrog the technological advances. Life sciences industry has-for decades now-moved from the traditional discovery-based drug development to target market-based drug development paradigm. Yet, it is burdened by long R&D cycles and labor-intensive clinical, manufacturing and compliancy regimens.
The industry is under tremendous pressure to accelerate drug development at an optimal cost, automate time- and labor-intensive tasks like document or report creation to preserve employee morale, and accelerate delivery.